UK: +44 (0)1223 264428
USA: +1 (650) 798 5134
Jeremy Kooyman contributes to article in PharmaField, June 16
Excerpt below; for full article go to PharmaField website
It might be before your time, but some of us remember how excited we were when 3D technology first burst onto the scene in the 1980s. Flimsy 3D glasses, complete with red and green lenses, were given away in cereal packets - this was the future and we could feel part of it. Then we quickly lost interest and 3D disappeared for decades. 3D films are now taken for granted by children of today, such is the pace of technology. But now 3D is finally being applied to healthcare and the infinite possibilities of 3D medicines, treatments and the pharmaceutical industry generally are something grown-ups are getting really excited about.
Indeed, 3D technology is shaping the future of the life sciences and pharma industry, and recently its impact on the wider healthcare landscape is beginning to be felt – we are at the dawn of a new age.
According to Design Engineer Jeremy Kooyman, of Cambridge Design Partnership, precision printing of pharmaceutical products will “fundamentally change how patients and payers interact with their pharmacists and the healthcare system”.
“Rather than a one-pill-fits-all approach, a pharmacist could modify a blueprint to tailor a treatment for a patient’s body mass or gene profile, while customising the shape and taste to encourage dosing compliance,” he elaborated. “You could even imagine combining multiple medicinal products together to reduce the number of pills a patient would need to take, drastically reducing the potential for under/overdoses, missed doses, and incorrect doses – all of which are linked with a startling rate of mortality in the developed world.”
Image courtesy Dassault Systémes
Demonstrating an innovative 'internet of things' solution to leak detection
Time-critical software development for swim tracking
Stay up to date with all our work and our latest news by signing up to our newsletter.